Synonym
PrivateLast Round
Series A
Oct 22, 2025
Total Funding Raised
$34.49M
Company Overview
Synonym operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in October 2025.
Synonym is a biotechnology infrastructure company that provides a financing and development platform to help companies scale and commercialize biomanufacturing facilities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synonym Comparables
Compare Synonym with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Boston Bioprocess | 78% | |
| Pow.Bio | 72% | |
| Culture Biosciences | 70% |
For institutional investors. Book with your work email.
Synonym Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 22, 2025 | ||||
| Grant | Aug 7, 2024 | ||||
| Grant | Nov 28, 2023 | ||||
| Pre Seed | Oct 14, 2022 | ||||
| Early Funding | Mar 14, 2022 |
For institutional investors. Book with your work email.
Synonym Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Pre Seed |
| Global Founders Capital | Pre Seed |
| Clocktower Ventures | Series A |
| Coefficient Giving | Grant |
| United States Department of Defense | Grant |
| GS Futures | Series A |
| Zero Infinity Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2025
Partnered with Brenntag Group for the 'Better with Bio' program.
- Oct 22, 2025
$20M round led by GS Futures.
For institutional investors. Book with your work email.
Synonym Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synonym's valuation, stock price, and market status.
Is Synonym a public or private company?
Synonym is a private company.
What is the current stock price of Synonym?
Synonym is a private company, so its shares have no public market price. Caplight tracks Synonym's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synonym worth (valuation)?
Valuation information for Synonym is not publicly available.
Can I buy Synonym stock?
Synonym shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synonym's last funding round?
Synonym's most recent funding round was Series A on October 22, 2025.
Who are the main investors in Synonym?
Key investors in Synonym include Andreessen Horowitz, United States Department of Defense, GS Futures, Blue Horizon, Open Philanthropy.
Will Synonym IPO soon?
No public IPO plans have been announced for Synonym.
How can I track Synonym secondary market activity?
Caplight tracks bids, offers, and trades in Synonym's shares on secondary markets.